Literature DB >> 25809481

Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.

Xun Chi1, Shwetha K Shetty1, Hannah W Shows1, Alexander J Hjelmaas1, Emily K Malcolm1, Brandon S J Davies2.   

Abstract

The release of fatty acids from plasma triglycerides for tissue uptake is critically dependent on the enzyme lipoprotein lipase (LPL). Hydrolysis of plasma triglycerides by LPL can be disrupted by the protein angiopoietin-like 4 (ANGPTL4), and ANGPTL4 has been shown to inactivate LPL in vitro. However, in vivo LPL is often complexed to glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) on the surface of capillary endothelial cells. GPIHBP1 is responsible for trafficking LPL across capillary endothelial cells and anchors LPL to the capillary wall during lipolysis. How ANGPTL4 interacts with LPL in this context is not known. In this study, we investigated the interactions of ANGPTL4 with LPL-GPIHBP1 complexes on the surface of endothelial cells. We show that ANGPTL4 was capable of binding and inactivating LPL complexed to GPIHBP1 on the surface of endothelial cells. Once inactivated, LPL dissociated from GPIHBP1. We also show that ANGPTL4-inactivated LPL was incapable of binding GPIHBP1. ANGPTL4 was capable of binding, but not inactivating, LPL at 4 °C, suggesting that binding alone was not sufficient for ANGPTL4's inhibitory activity. We observed that although the N-terminal coiled-coil domain of ANGPTL4 by itself and full-length ANGPTL4 both bound with similar affinities to LPL, the N-terminal fragment was more potent in inactivating both free and GPIHBP1-bound LPL. These results led us to conclude that ANGPTL4 can both bind and inactivate LPL complexed to GPIHBP1 and that inactivation of LPL by ANGPTL4 greatly reduces the affinity of LPL for GPIHBP1.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Endothelial Cell; Lipase; Lipolysis; Lipoprotein Metabolism; Triglyceride

Mesh:

Substances:

Year:  2015        PMID: 25809481      PMCID: PMC4424327          DOI: 10.1074/jbc.M114.623769

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Regulation of lipoprotein lipase by Angptl4.

Authors:  Wieneke Dijk; Sander Kersten
Journal:  Trends Endocrinol Metab       Date:  2014-01-04       Impact factor: 12.015

2.  Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.

Authors:  Remco Franssen; Stephen G Young; Frank Peelman; Jozef Hertecant; Jeroen A Sierts; Alinda W M Schimmel; André Bensadoun; John J P Kastelein; Loren G Fong; Geesje M Dallinga-Thie; Anne P Beigneux
Journal:  Circ Cardiovasc Genet       Date:  2010-02-02

3.  Rates of lipid fluxes in adipose tissue in vivo after a mixed meal in morbid obesity.

Authors:  P Mitrou; E Boutati; V Lambadiari; E Maratou; V Komesidou; A Papakonstantinou; L Sidossis; N Tountas; N Katsilambros; T Economopoulos; S A Raptis; G Dimitriadis
Journal:  Int J Obes (Lond)       Date:  2010-01-19       Impact factor: 5.095

4.  Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation.

Authors:  Michael J Lafferty; Kira C Bradford; Dorothy A Erie; Saskia B Neher
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

5.  Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample.

Authors:  Marius R Robciuc; Esa Tahvanainen; Matti Jauhiainen; Christian Ehnholm
Journal:  J Lipid Res       Date:  2009-10-13       Impact factor: 5.922

Review 6.  Physiological regulation of lipoprotein lipase.

Authors:  Sander Kersten
Journal:  Biochim Biophys Acta       Date:  2014-04-08

7.  The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries.

Authors:  Chris N Goulbourne; Peter Gin; Angelica Tatar; Chika Nobumori; Andreas Hoenger; Haibo Jiang; Chris R M Grovenor; Oludotun Adeyo; Jeffrey D Esko; Ira J Goldberg; Karen Reue; Peter Tontonoz; André Bensadoun; Anne P Beigneux; Stephen G Young; Loren G Fong
Journal:  Cell Metab       Date:  2014-04-10       Impact factor: 27.287

8.  Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits.

Authors:  Nidhi Mehta; Arman Qamar; Liming Qu; Atif N Qasim; Nehal N Mehta; Muredach P Reilly; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-13       Impact factor: 8.311

9.  GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4.

Authors:  William K Sonnenburg; Daiguan Yu; E-Chiang Lee; Wei Xiong; Gennady Gololobov; Billie Key; Jason Gay; Nat Wilganowski; Yi Hu; Sharon Zhao; Matthias Schneider; Zhi-Ming Ding; Brian P Zambrowicz; Greg Landes; David R Powell; Urvi Desai
Journal:  J Lipid Res       Date:  2009-06-21       Impact factor: 5.922

10.  Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion.

Authors:  T Adhikary; D T Brandt; K Kaddatz; J Stockert; S Naruhn; W Meissner; F Finkernagel; J Obert; S Lieber; M Scharfe; M Jarek; P M Toth; F Scheer; W E Diederich; S Reinartz; R Grosse; S Müller-Brüsselbach; R Müller
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

View more
  24 in total

1.  The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding.

Authors:  Katrine Z Leth-Espensen; Kristian K Kristensen; Anni Kumari; Anne-Marie L Winther; Stephen G Young; Thomas J D Jørgensen; Michael Ploug
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

2.  Novel GPIHBP1-independent pathway for clearance of plasma TGs in Angptl4-/-Gpihbp1-/- mice.

Authors:  Emily M Cushing; Kelli L Sylvers; Xun Chi; Shwetha K Shetty; Brandon S J Davies
Journal:  J Lipid Res       Date:  2018-05-08       Impact factor: 5.922

Review 3.  ANGPTL4 in Metabolic and Cardiovascular Disease.

Authors:  Binod Aryal; Nathan L Price; Yajaira Suarez; Carlos Fernández-Hernando
Journal:  Trends Mol Med       Date:  2019-06-21       Impact factor: 11.951

4.  Biochemical Analysis of the Lipoprotein Lipase Truncation Variant, LPLS447X, Reveals Increased Lipoprotein Uptake.

Authors:  Cassandra K Hayne; Michael J Lafferty; Brian J Eglinger; John P Kane; Saskia B Neher
Journal:  Biochemistry       Date:  2017-01-09       Impact factor: 3.162

5.  A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time.

Authors:  Shwetha K Shetty; Rosemary L Walzem; Brandon S J Davies
Journal:  J Lipid Res       Date:  2020-02-06       Impact factor: 5.922

6.  Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry.

Authors:  Mart Reimund; Oleg Kovrov; Gunilla Olivecrona; Aivar Lookene
Journal:  J Lipid Res       Date:  2016-11-14       Impact factor: 5.922

Review 7.  GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.

Authors:  Stephen G Young; Loren G Fong; Anne P Beigneux; Christopher M Allan; Cuiwen He; Haibo Jiang; Katsuyuki Nakajima; Muthuraman Meiyappan; Gabriel Birrane; Michael Ploug
Journal:  Cell Metab       Date:  2019-07-02       Impact factor: 27.287

Review 8.  An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.

Authors:  Ren Zhang; Kezhong Zhang
Journal:  Prog Lipid Res       Date:  2021-11-16       Impact factor: 16.195

9.  Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.

Authors:  Wieneke Dijk; Anne P Beigneux; Mikael Larsson; André Bensadoun; Stephen G Young; Sander Kersten
Journal:  J Lipid Res       Date:  2016-03-31       Impact factor: 5.922

Review 10.  Lipoprotein Lipase and Its Regulators: An Unfolding Story.

Authors:  Shuangcheng Alivia Wu; Sander Kersten; Ling Qi
Journal:  Trends Endocrinol Metab       Date:  2020-12-01       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.